Immediate Insulin Dose Reduction for Nocturnal Hypoglycemia
Reduce the evening (8 pm) Lantus dose by 10-20% immediately—from 34 units to 27-31 units—while keeping the morning dose unchanged at 34 units. 1
Understanding the Problem
Your patient is experiencing nocturnal hypoglycemia at 2 am (blood glucose 61 mg/dL), which indicates excessive insulin action during the overnight period. 1 The evening dose of Lantus is providing too much basal insulin coverage during sleep hours, creating a dangerous situation that requires immediate adjustment. 1
Specific Dose Adjustment Algorithm
For this isolated nocturnal hypoglycemia event:
- Reduce the 8 pm dose by 10-20% (from 34 units to 27-31 units) 1
- Use a 20% reduction (to 27 units) if this is severe or recurrent hypoglycemia 1
- Use a 10% reduction (to 31 units) if this is mild and isolated 1
- Keep the morning 8 am dose at 34 units unchanged, as it is not contributing to the nocturnal hypoglycemia 1, 2
The guideline is clear: when no reversible cause is identified for hypoglycemia, reduce the corresponding insulin dose by 10-20%. 3, 1
Critical Monitoring Requirements
Intensify glucose monitoring immediately after this dose adjustment: 1
- Check blood glucose at 2-3 am for several consecutive nights to confirm resolution of nocturnal hypoglycemia 1, 2
- Check fasting blood glucose daily for at least one week 1
- Also check at bedtime and upon waking for several days 1
- Target fasting glucose range of 80-130 mg/dL 1
Subsequent Titration Strategy
After one week of the reduced evening dose: 1
- If more than 50% of fasting glucose values remain above target, increase by 2 units 1
- If two or more fasting glucose values per week fall below 80 mg/dL, decrease by an additional 2 units 1
- Make adjustments every 3 days during active titration 3, 1
Immediate Treatment of the Current Episode
For the current hypoglycemic episode (BG 61 mg/dL): 4, 5
- Administer 15-20 grams of glucose using glucose tablets or carbohydrate-containing foods/beverages 4
- Recheck blood glucose after 15 minutes 4, 2
- Repeat the glucose dose if levels remain low 4
- For severe hypoglycemia with altered consciousness, administer glucagon 1 mg subcutaneously 2, 5
Critical Pitfalls to Avoid
Do not continue the same dose without adjustment—this significantly increases the risk of recurrent severe hypoglycemia, which can lead to hypoglycemia unawareness and impaired counterregulatory responses. 1, 4 Nocturnal hypoglycemia is associated with serious complications including cardiac arrhythmias and the "dead-in-bed syndrome." 6
Do not reduce both the morning and evening doses simultaneously—only the evening dose is causing the nocturnal hypoglycemia. 2 Reducing both doses unnecessarily increases the risk of daytime hyperglycemia. 2
Do not skip the evening dose entirely—this will cause uncontrolled fasting hyperglycemia. 2
When to Consider Alternative Strategies
If nocturnal hypoglycemia persists despite dose reduction, consider: 1, 4
- Switching Lantus administration from evening to morning to reduce nocturnal hypoglycemia risk while maintaining 24-hour coverage 1
- Switching to newer ultra-long-acting basal analogs (insulin degludec or U-300 glargine), which have lower nocturnal hypoglycemia rates than U-100 glargine 1, 4, 7
- Splitting to twice-daily Lantus if once-daily dosing continues to cause problems 8
Evaluate for overbasalization: 3, 1, 4
- Look for clinical signals including basal dose exceeding 0.5 units/kg/day 3, 1
- High bedtime-to-morning glucose differential 1, 4
- High glucose variability 4
In this patient receiving 68 units total daily (34 units twice daily), assess whether this represents overbasalization based on body weight. 3, 1
Glucagon Prescription
All patients on basal insulin should have glucagon available for emergency use. 3, 1 Ensure this patient has a glucagon prescription if not already provided. 3
Follow-Up Timing
Schedule reassessment within 1-2 weeks after the dose reduction to review glucose logs, identify patterns, and make further adjustments as needed. 1